Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2024-04-22 00:00:00 ET · period of report 2024-04-18 · accession 0001437749-24-012643 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-22 | 2024-04-18 | FLNA | Kupiec James William | Chief Medical Off | M - OptEx | $22.00 | +1,500 | 4,000 | +60% | +$33.0K |
| D | 2024-04-22 | 2024-04-18 | FLNA | Kupiec James William | Chief Medical Off | M - OptEx | $0.00 | -1,000 | 0 | -100% | $0 |
| D | 2024-04-22 | 2024-01-03 | FLNA | Kupiec James William | Chief Medical Off | A - Grant | $0.00 | +1,000 | 1,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-18 | M | A | 1,500 | $22.00 | 4,000 | D | — | — | (F2) Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised. |
| 2 | Derivative | Common Stock Warrant | 2024-04-18 | M | D | 1,000 | $0.00 | 0 | D | $33.00 · 2024-01-03 to 2024-05-07 | 1,500 Common Stock | |
| 3 | Derivative | Common Stock Warrant | 2024-01-03 | A | A | 1,000 | $0.00 | 1,000 | D | $33.00 · 2024-01-03 to 2024-05-07 | 1,500 Common Stock | (F1) Represents warrants that were originally issued on January 3, 2024 as a distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16. |